Royal Bank of Canada’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,611
| Closed | -$64K | – | 7744 |
|
|
2024
Q1 | $64K | Sell |
1,611
-8,533
| -84% | -$252K | ﹤0.01% | 5427 |
|
|
2023
Q4 | $193K | Buy |
10,144
+3,821
| +60% | +$53.1K | ﹤0.01% | 5135 |
|
|
2023
Q3 | $72K | Buy |
6,323
+3,681
| +139% | +$45.3K | ﹤0.01% | 5583 |
|
|
2023
Q2 | $27K | Buy |
2,642
+1,315
| +99% | +$11.9K | ﹤0.01% | 6066 |
|
|
2023
Q1 | $10K | Sell |
1,327
-1,828
| -58% | -$14.6K | ﹤0.01% | 6345 |
|
|
2022
Q4 | $23K | Buy |
3,155
+2,965
| +1,561% | +$18.9K | ﹤0.01% | 6251 |
|
|
2022
Q3 | $1K | Buy |
190
+102
| +116% | +$841 | ﹤0.01% | 7326 |
|
|
2022
Q2 | $1K | Sell |
88
-625
| -88% | -$5.39K | ﹤0.01% | 7251 |
|
|
2022
Q1 | $6K | Sell |
713
-1,899
| -73% | -$16.4K | ﹤0.01% | 7215 |
|
|
2021
Q4 | $36K | Buy |
2,612
+1,429
| +121% | +$17.7K | ﹤0.01% | 6559 |
|
|
2021
Q3 | $12K | Buy |
1,183
+388
| +49% | +$3.58K | ﹤0.01% | 6912 |
|
|
2021
Q2 | $7K | Buy |
+795
| New | +$8.64K | ﹤0.01% | 6999 |
|
|
2021
Q1 | – | Sell |
-8
| Closed | – | – | 7768 |
|
|
2020
Q4 | $0 | Sell |
8
-95
| -92% | -$932 | ﹤0.01% | 7356 |
|
|
2020
Q3 | $1K | Sell |
103
-8,250
| -99% | -$75.4K | ﹤0.01% | 6505 |
|
|
2020
Q2 | $81K | Buy |
8,353
+3,002
| +56% | +$13K | ﹤0.01% | 4982 |
|
|
2020
Q1 | $15K | Buy |
5,351
+5,100
| +2,032% | +$15.9K | ﹤0.01% | 5681 |
|
|
2019
Q4 | $1K | Sell |
251
-106
| -30% | -$330 | ﹤0.01% | 6711 |
|
|
2019
Q3 | $1K | Buy |
357
+107
| +43% | +$459 | ﹤0.01% | 6543 |
|
|
2019
Q2 | $1K | Sell |
250
-500
| -67% | -$2.89K | ﹤0.01% | 6760 |
|
|
2019
Q1 | $5K | Hold |
750
| – | – | ﹤0.01% | 6293 |
|
|
2018
Q4 | $3K | Hold |
750
| – | – | ﹤0.01% | 6381 |
|
|
2018
Q3 | $5K | Hold |
750
| – | – | ﹤0.01% | 6292 |
|
|
2018
Q2 | $6K | Hold |
750
| – | – | ﹤0.01% | 6002 |
|
|
2018
Q1 | $6K | Hold |
750
| – | – | ﹤0.01% | 5897 |
|
|
2017
Q4 | $8K | Buy |
750
+499
| +199% | +$5.43K | ﹤0.01% | 5949 |
|
|
2017
Q3 | $3K | Buy |
+251
| New | +$2.35K | ﹤0.01% | 6527 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | – | – | 6828 |
|
|
2017
Q1 | $0 | Buy |
+1
| New | +$10 | ﹤0.01% | 6879 |
|
|
2015
Q4 | – | Sell |
-50
| Closed | -$3K | – | 6865 |
|
|
2015
Q3 | $3K | Buy |
+50
| New | +$3.29K | ﹤0.01% | 6317 |
|
Royal Bank of Canada's ALPN Position: Q2 2024 in Review
Royal Bank of Canada sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,611 shares — an estimated $64K sold.
Royal Bank of Canada first reported a position in ALPN in Q3 2015 and held it in 28 quarters. The position peaked at $193K in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Royal Bank of Canada reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Royal Bank of Canada sold 1,611 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $64K.
- Royal Bank of Canada first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 28 quarters.
- Royal Bank of Canada's Alpine Immune Sciences Inc position peaked at $193K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.